Next Article in Journal
Diagnosis and Management of Hyponatremia in Patients with Aneurysmal Subarachnoid Hemorrhage
Next Article in Special Issue
Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics
Previous Article in Journal
Endoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the Ugly
Previous Article in Special Issue
Biological Treatments in Atopic Dermatitis
Article Menu

Export Article

Open AccessReview
J. Clin. Med. 2015, 4(4), 741-755; doi:10.3390/jcm4040741

Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?

Department of Dermatology, University of Rochester Medical Center, Rochester, NY 14642, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Sebastien Barbarot and Kim Thomas
Received: 4 February 2015 / Revised: 30 March 2015 / Accepted: 1 April 2015 / Published: 21 April 2015
(This article belongs to the Special Issue Epidemiology and Treatment of Atopic Eczema)
View Full-Text   |   Download PDF [403 KB, uploaded 21 April 2015]   |  

Abstract

Atopic Dermatitis (AD), the most common chronic inflammatory skin disease, is characterized by an overactive immune response to a host of environmental allergens and dry, itchy skin. Over the past decade important discoveries have demonstrated that AD develops in part from genetic and/or acquired defects in the skin barrier. Histamine is an aminergic neurotransmitter involved in physiologic and pathologic processes such as pruritus, inflammation, and vascular leak. Enhanced histamine release has been observed in the skin of patients with AD and antihistamines are often prescribed for their sedating and anti-itch properties. Recent evidence suggests that histamine also inhibits the terminal differentiation of keratinocytes and impairs the skin barrier, raising the question whether histamine might play a role in AD barrier impairment. This, coupled with the notion that histamine’s effects mediated through the recently identified histamine receptor H4R, may be important in allergic inflammation, has renewed interest in this mediator in allergic diseases. In this paper we summarize the current knowledge on histamine and histamine receptor antagonists in AD and skin barrier function. View Full-Text
Keywords: atopic dermatitis; histamine; histamine receptors; skin barrier; tight junction atopic dermatitis; histamine; histamine receptors; skin barrier; tight junction
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

De Benedetto, A.; Yoshida, T.; Fridy, S.; Park, J.-E.S.; Kuo, I.-H.; Beck, L.A. Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis? J. Clin. Med. 2015, 4, 741-755.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top